Poudel Rishi R, Tiwari Vivek, Kumar Venkatesan S, Bakhshi Sameer, Gamanagatti Shivanand, Khan Shah Alam, Rastogi Shishir
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India.
Department of Medical Oncology, Dr. B.R.A. Institute, Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
J Surg Oncol. 2017 Apr;115(5):631-636. doi: 10.1002/jso.24602. Epub 2017 Apr 25.
Local control of disease is one of the main goals of osteosarcoma management. We conducted a retrospective evaluation of 95 operated cases of osteosarcoma over 7 years to know about the factors associated with local recurrence in resource-challenged environment of the developing world.
The factors which were evaluated and compared between local recurrence and non-local recurrence groups included demographic profile, site of tumor, whether biopsy done outside, type of surgery (limb salvage or amputation), presence of pathological fracture, vicinity of neurovascular bundle, tumor volume, histological subtype, chemotherapy induced necrosis, surgical margins, and delay in surgery. The time to local recurrence after surgery was also noted in the local recurrence group.
At a mean follow-up of 2.8 years, biopsy done from outside the treating center and delay in surgery after completion of neo-adjuvant chemotherapy emerged as significant risk factors for local recurrence. Most of the local recurrences (80%) occurred within 12 months of the primary surgery.
Lack of financial resources and availability of few tertiary care centers dealing with musculoskeletal oncology in the developing countries, lead to overburden with a long waiting list for tumor surgery making the scenario different from the Western world.
疾病的局部控制是骨肉瘤治疗的主要目标之一。我们对7年间95例骨肉瘤手术病例进行了回顾性评估,以了解在发展中国家资源有限的环境中与局部复发相关的因素。
在局部复发组和非局部复发组之间进行评估和比较的因素包括人口统计学特征、肿瘤部位、是否在外部进行活检、手术类型(保肢或截肢)、病理性骨折的存在、神经血管束的邻近情况、肿瘤体积、组织学亚型、化疗诱导的坏死、手术切缘以及手术延迟。在局部复发组中还记录了手术后局部复发的时间。
平均随访2.8年,在治疗中心以外进行活检以及新辅助化疗完成后手术延迟是局部复发的重要危险因素。大多数局部复发(80%)发生在初次手术后12个月内。
发展中国家缺乏财政资源且处理肌肉骨骼肿瘤的三级护理中心数量有限,导致肿瘤手术等待名单过长,负担过重,使得情况与西方世界不同。